Source: Annual Congress 2006 - Markers of paediatric airway disease
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. M. Robroeks, K. D. van de Kant, Q. Jöbsis, D. van Vliet, H. J. Hendriks, M. F. Wouters, P. P. Rosias, J. G. Damoiseaux, W. W. Wodzig, E. Dompeling (Maastricht, Sittard, Netherlands). Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma. Eur Respir J 2006; 28: Suppl. 50, 786

Member's Comments

No comment yet.

Related content which might interest you: Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 Do exhaled non-invasive inflammatory markers correlate with respiratory symptoms and lung function in a longitudinal study of childhood asthma? Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 COPD exacerbation definitions, assessment and diagnosis Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 COPD: problems in diagnosis and measurement Source: Eur Respir J 2003; 21: 4S-12S Year: 2003 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD Year: 2021 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Non-invasive markers of inflammation as a measurement of corticosteroid responsiveness in children with severe asthma (sa) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018 The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019 Is pulmonary index score suitable for the evaluation of paediatric acute asthma Source: Breathe 2011; 7: 372-373 Year: 2011